NCT03739541 is a Phase 1 clinical trial of [14C]-Benznidazole in Healthy Male Subjects, sponsored by Exeltis France.

Who is sponsoring NCT03739541?

NCT03739541 is sponsored by Exeltis France.

What drugs are being tested in NCT03739541?

Interventions in NCT03739541: [14C]-Benznidazole.

What condition does NCT03739541 study?

NCT03739541 studies Healthy Male Subjects.

Is NCT03739541 still recruiting?

NCT03739541 is currently completed. Last updated 14 November 2018.

Last reviewed 2018-11-14 · How we verify

NCT03739541

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Benznidazole Absorption, Metabolism and Excretion Study

Completed Phase 1 Last updated 14 November 2018

What this trial tests

Phase 1 trial testing [14C]-Benznidazole in Healthy Male Subjects in 6 participants. Completed in 2 September 2018.

Timeline

16 July 2018

Primary endpoint
2 September 2018

2 September 2018

Quick facts

Lead sponsor	Exeltis France
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	basic science
Enrollment	6
Start date	16 July 2018
Primary completion	2 September 2018
Estimated completion	2 September 2018
Sites	1 location across United Kingdom

Drugs / interventions tested

[14C]-Benznidazole — full drug profile →

Conditions studied

Healthy Male Subjects — all drugs for Healthy Male Subjects →

Sponsor

Exeltis France — full company profile →

Who can join

Adults 35 to 65, male only, with Healthy Male Subjects. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This Phase I ADME study will be conducted to evaluate the pharmacokinetics of benznidazole.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy Male Subjects

Currently open trials in the same condition.

NCT07340476 — A Study to Evaluate the PK Similarity of AK112 in Healthy Chinese Male Subjects · Phase 1 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03739541 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Exeltis France
Last refreshed: 14 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03739541.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing